Header Logo

Connection

Greg Wolf to Laryngeal Neoplasms

This is a "connection" page, showing publications Greg Wolf has written about Laryngeal Neoplasms.
Connection Strength

4.681
  1. Wolf GT, Bellile E, Eisbruch A, Urba S, Bradford CR, Peterson L, Prince ME, Teknos TN, Chepeha DB, Hogikyan ND, McLean SA, Moyer J, Taylor JMG, Worden FP. Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2017 04 01; 143(4):355-366.
    View in: PubMed
    Score: 0.549
  2. Wolf GT. Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited. Head Neck. 2010 Jan; 32(1):7-14.
    View in: PubMed
    Score: 0.332
  3. Worden FP, Moyer J, Lee JS, Taylor JM, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Hogikyan N, Lassig AA, Emerick K, Mukherji S, Hadjiski L, Tsien CI, Miller TH, Wallace NE, Mason HL, Bradford CR, Wolf GT. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope. 2009 Aug; 119(8):1510-7.
    View in: PubMed
    Score: 0.323
  4. Benjamin WJ, Feng AL, Heft Neal M, Bellile E, Casper KA, Malloy KM, Rosko AJ, Stucken CL, Prince ME, Mierzwa ML, Taylor JMG, Eisbruch A, Spector ME, Wolf GT, Swiecicki PL, Worden FP, Chinn SB. Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer. Oral Oncol. 2024 Sep; 156:106917.
    View in: PubMed
    Score: 0.227
  5. Teknos TN, Cox C, Barrios MA, Chepeha DB, Bradford CR, Fisher SG, Wolf GT. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma. Laryngoscope. 2002 May; 112(5):844-51.
    View in: PubMed
    Score: 0.195
  6. Swiecicki PL, Bellile E, Casper K, Chinn SB, Dragovic AF, Jolly S, Kupfer R, Malloy KM, Mierzwa ML, Shuman AG, Spector ME, Srinivasan A, Stucken C, Bradford CR, Eisbruch A, Carey TE, Prince ME, Wolf GT, Worden FP. Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor. Head Neck. 2022 07; 44(7):1509-1519.
    View in: PubMed
    Score: 0.195
  7. Heft Neal ME, Smith JD, Birkeland AC, Haring CT, Chinn SB, Shuman AG, Casper KA, Malloy KM, Stucken CL, Mclean SA, Rosko AJ, Mierzwa ML, Shah J, Schonewolf C, Swiecicki PL, Worden FP, Wolf GT, Bradford CR, Prince MEP, Brenner JC, Spector ME. Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing Bioselection. Otolaryngol Head Neck Surg. 2022 03; 166(3):498-505.
    View in: PubMed
    Score: 0.183
  8. Farlow JL, Birkeland AC, Hardenbergh A, Lyden T, Brenner JC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Rosko AJ, Spector ME. Speech and swallowing outcomes after laryngectomy for the dysfunctional irradiated larynx. Eur Arch Otorhinolaryngol. 2020 May; 277(5):1459-1465.
    View in: PubMed
    Score: 0.167
  9. Farlow JL, Birkeland AC, Rosko AJ, VanKoevering K, Haring CT, Smith JD, Brenner JC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, McLean SA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Spector ME. Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy. Ann Surg Oncol. 2019 Aug; 26(8):2542-2548.
    View in: PubMed
    Score: 0.157
  10. Smith JD, Birkeland AC, Rosko AJ, Hoesli RC, Foltin SK, Swiecicki P, Mierzwa M, Chinn SB, Shuman AG, Malloy KM, Casper KA, McLean SA, Wolf GT, Bradford CR, Prince ME, Brenner JC, Spector ME. Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma. Head Neck. 2019 02; 41(2):423-428.
    View in: PubMed
    Score: 0.154
  11. Rosko AJ, Birkeland AC, Bellile E, Kovatch KJ, Miller AL, Jaffe CC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Spector ME. Hypothyroidism and Wound Healing After Salvage Laryngectomy. Ann Surg Oncol. 2018 May; 25(5):1288-1295.
    View in: PubMed
    Score: 0.144
  12. Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG. Individualized outcome prognostication for patients with laryngeal cancer. Cancer. 2018 02 15; 124(4):706-716.
    View in: PubMed
    Score: 0.143
  13. Birkeland AC, Beesley L, Bellile E, Rosko AJ, Hoesli R, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma. Head Neck. 2017 12; 39(12):2512-2518.
    View in: PubMed
    Score: 0.142
  14. Gainor DL, Marchiano E, Bellile E, Spector ME, Taylor JMG, Wolf GT, Hogikyan ND, Prince ME, Bradford CR, Eisbruch A, Worden F, Shuman AG. Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx. Otolaryngol Head Neck Surg. 2017 10; 157(4):625-630.
    View in: PubMed
    Score: 0.139
  15. Birkeland AC, Rosko AJ, Beesley L, Bellile E, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME. Preoperative Tracheostomy Is Associated with Poor Disease-Free Survival in Recurrent Laryngeal Cancer. Otolaryngol Head Neck Surg. 2017 09; 157(3):432-438.
    View in: PubMed
    Score: 0.139
  16. Rosko A, Birkeland A, Shuman A, Prince M, Bradford C, Wolf G, Worden F, Eisbruch A, Srinivasan A, Wong KK, Spector ME. Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer. Head Neck. 2017 05; 39(5):980-987.
    View in: PubMed
    Score: 0.136
  17. Sanabria A, Chaves ALF, Kowalski LP, Wolf GT, Saba NF, Forastiere AA, Beitler JJ, Nibu KI, Bradford CR, Su?rez C, Rodrigo JP, Strojan P, Rinaldo A, de Bree R, Haigentz M, Takes RP, Ferlito A. Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials. Auris Nasus Larynx. 2017 Feb; 44(1):18-25.
    View in: PubMed
    Score: 0.130
  18. Scheel A, Bellile E, McHugh JB, Walline HM, Prince ME, Urba S, Wolf GT, Eisbruch A, Worden F, Carey TE, Bradford C. Classification of TP53 mutations and HPV predict survival in advanced larynx cancer. Laryngoscope. 2016 09; 126(9):E292-9.
    View in: PubMed
    Score: 0.130
  19. Birkeland AC, Rosko AJ, Issa MR, Shuman AG, Prince ME, Wolf GT, Bradford CR, McHugh JB, Brenner JC, Spector ME. Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy. Otolaryngol Head Neck Surg. 2016 Mar; 154(3):473-9.
    View in: PubMed
    Score: 0.127
  20. Vainshtein JM, Wu VF, Spector ME, Bradford CR, Wolf GT, Worden FP. Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer. Expert Rev Anticancer Ther. 2013 Sep; 13(9):1053-64.
    View in: PubMed
    Score: 0.107
  21. Bradford CR, Kumar B, Bellile E, Lee J, Taylor J, D'Silva N, Cordell K, Kleer C, Kupfer R, Kumar P, Urba S, Worden F, Eisbruch A, Wolf GT, Teknos TN, Prince ME, Chepeha DB, Hogikyan ND, Moyer JS, Carey TE. Biomarkers in advanced larynx cancer. Laryngoscope. 2014 Jan; 124(1):179-87.
    View in: PubMed
    Score: 0.106
  22. Dewyer NA, Wolf GT, Light E, Worden F, Urba S, Eisbruch A, Bradford CR, Chepeha DB, Prince ME, Moyer J, Taylor J. Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer. Head Neck. 2014 Jan; 36(1):9-14.
    View in: PubMed
    Score: 0.106
  23. Strojan P, Haigentz M, Bradford CR, Wolf GT, Hartl DM, Langendijk JA, Rinaldo A, Eisbruch A, Mendenhall WM, Forastiere AA, Takes RP, Ferlito A. Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. Oral Oncol. 2013 Apr; 49(4):283-6.
    View in: PubMed
    Score: 0.102
  24. Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G. A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group. Arch Otolaryngol Head Neck Surg. 2009 Sep; 135(9):869-74.
    View in: PubMed
    Score: 0.081
  25. Emerick KS, Tomycz L, Bradford CR, Lyden TH, Chepeha DB, Wolf GT, Teknos TN. Primary versus secondary tracheoesophageal puncture in salvage total laryngectomy following chemoradiation. Otolaryngol Head Neck Surg. 2009 Mar; 140(3):386-90.
    View in: PubMed
    Score: 0.078
  26. Kumar B, Cordell KG, D'Silva N, Prince ME, Adams ME, Fisher SG, Wolf GT, Carey TE, Bradford CR. Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2008 Apr; 134(4):363-9.
    View in: PubMed
    Score: 0.074
  27. Wolf GT. Integrating surgery into treatment paradigms for organ preservation: tailoring treatment to biology improves outcomes. Int J Radiat Oncol Biol Phys. 2007; 69(2 Suppl):S4-7.
    View in: PubMed
    Score: 0.067
  28. Jones DA, Dillard SC, Bradford CR, Wolf GT, Prince ME. Cartilaginous tumours of the larynx. J Otolaryngol. 2003 Oct; 32(5):332-7.
    View in: PubMed
    Score: 0.054
  29. Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck. 2002 Nov; 24(11):1004-11.
    View in: PubMed
    Score: 0.051
  30. Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope. 2002 Apr; 112(4):638-44.
    View in: PubMed
    Score: 0.049
  31. Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, Endicott JW, McClatchey K, Henderson WG. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991 06 13; 324(24):1685-90.
    View in: PubMed
    Score: 0.023
  32. Tabor MH, Clay MR, Owen JH, Bradford CR, Carey TE, Wolf GT, Prince ME. Head and neck cancer stem cells: the side population. Laryngoscope. 2011 Mar; 121(3):527-33.
    View in: PubMed
    Score: 0.022
  33. Prince ME, Ubell ML, Castro J, Ogawa H, Ogawa T, Narayan A, Paulino A, Cole A, Wolf GT, Rubin MA, Lyons RH, Bradford CR, Carey TE. Tissue-preserving approach to extracting DNA from paraffin-embedded specimens using tissue microarray technology. Head Neck. 2007 May; 29(5):465-71.
    View in: PubMed
    Score: 0.017
  34. Fung K, Teknos TN, Vandenberg CD, Lyden TH, Bradford CR, Hogikyan ND, Kim J, Prince ME, Wolf GT, Chepeha DB. Prevention of wound complications following salvage laryngectomy using free vascularized tissue. Head Neck. 2007 May; 29(5):425-30.
    View in: PubMed
    Score: 0.017
  35. Moyer JS, Wolf GT, Bradford CR. Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2004 Apr; 12(2):82-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.